The prevalence of hyperprolactinaemia and association with markers of autoimmune thyroid disease in survivors of the Whickham Survey cohort

Clinical Endocrinology

Volumn 48, Issue 1, 1998, Pages 39-44

  Vanderpump, M P J ^a   French, J M ^b   Appleton, D ^b   Tunbridge, W M G ^c   Kendall Taylor, P ^d  

^a NORTH MIDDLESEX UNIVERSITY HOSPITAL   (United Kingdom)

^b NEWCASTLE UNIVERSITY   (United Kingdom)

^c JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^d NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PROLACTIN;

ADULT; AGED; ARTICLE; AUTOIMMUNITY; COHORT ANALYSIS; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW UP; HUMAN; HYPERPROLACTINEMIA; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; PROLACTIN BLOOD LEVEL; SURVIVAL; THYROID DISEASE;

ADULT; AGED; AGED, 80 AND OVER; CROSS-SECTIONAL STUDIES; ENGLAND; FEMALE; FOLLOW-UP STUDIES; HEALTH SURVEYS; HUMANS; HYPERPROLACTINEMIA; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PREVALENCE; SEX DISTRIBUTION; THYROIDITIS, AUTOIMMUNE;

EID: 0031912370     PISSN: 03000664     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2265.1998.00343.x     Document Type: Article

References (24)

1. Anonymous (1987) Hyperprolactinaemia: when is a prolactinoma not a prolactinoma? Lancet, ii, 1002-1004.
2. Bevan, J.S., Burke, C.W., Esiri, M.M. & Adams, C.B.T. (1987) Misinterpretation of prolactin levels leading to management errors in patients with sellar enlargement. American Journal of Medicine, 82, 29-32.
3. Blackwell, R.E. (1992) Hyperprolactinaemia. Evaluation and management. Endocrinology and Metabolism Clinics of North America, 21, 105-124.
4. Brooks, J.E., Herbert, M., Walder, C.P., Selby, C. & Jeffcoate, W.J. (1986) Prolactin and stress: some endocrine correlates of pre-operative anxiety. Clinical Endocrinology, 24, 653-656.
5. Burrow, G.N., Wortzman, G., Rewcastle, N.B., Holgate, R.C. & Lovacs, K. (1981) Microadenomas of the pituitary and abnormal sellar tomograms in an unselected autopsy series. New England Journal of Medicine, 304, 156-158.
6. Cunnah, D. & Besser, M. (1991) Management of prolactinomas. Clinical Endocrinology, 34, 231-235.
7. Jeffcoate, S.L. (1978) Diagnosis of hyperprolactinaemia. Lancet, ii, 1245-1247.
8. Jeffcoate, S.L., Bacon, R.R.A., Beastall, G.H., Diver, M.J., Franks, S. & Seth, J. (1986) Assay for prolactin: guidelines for the provision of a clinical biochemistry service. Annals of Clinical Biochemistry, 23, 638-651.
9. Jeffcoate, W.J., Pound, N., Sturrock, N.D.C. & Lambourne, J. (1996) Long-term follow-up of patients with hyperprolactinemia. Clinical Endocrinology, 45, 299-303.
10. Katevuo, K., Valimaki, M., Ketnen, L., Lamberg, B.A. & Pelkowen, R. (1985) Computed tomography of the pituitary fossa in primary hypothyroidism. Effect of thyroid treatment. Clinical Endocrinology, 22, 617-621.
11. Martin, T.L., Kim, M. & Malarkey, W.B. (1985) The natural history of idiopathic hyperprolactinemia. Journal of Clinical Endocrinology and Metabolism, 60, 855-858.
12. Miyai, K., Ichihara, K., Kondo, K. & Mori, S. (1986) Asymptomatic hyperprolactinaemia and prolactinoma in the general population - mass screening by paired assays of serum prolactin. Clinical Endocrinology, 25, 549-554.
13. Miyake, A., Ikegemi, M., Chen, C-F., Arita, N., Aono, T., Tanizawa, O. & Yoshikawa, T. (1988) Mass screening for hyperprolactinemia and prolactinoma in men. Journal of Endocrinological Investigation, 11, 383-384.
14. Ross, R.J.M., Grossman, A., Bouloux, P.M.G., Rees, L.H., Doniach, I. & Besser, G.M. (1985) The relationship between serum prolactin and immunocytochemical staining for prolactin in patients with pituitary macroadenomas. Clinical Endocrinology, 23, 227-235.
15. Semple, C.G., Gray, C.E., Borland, W., Espie, C.E. & Beastall, G.H. (1988) Endocrine effects of examination stress. Clinical Science, 74, 255-259.
16. Sluijmer, A.V. & Lappöhn, R.E. (1992) Clinical history and outcome of 59 patients with idiopathic hyperprolactinemia. Fertility and Sterility, 58, 72-77.
17. Snyder, P.J. (1996) The pituitary in hypothyroidism. In Werner and Ingbar's The Thyroid: A Fundamental and Clinical Text, 7th edn, (eds L.E. Braverman & R.D. Utiger), pp. 836-840. J.B. Lippencott-Raven, Philadelphia, New York.
18. Stewart, P.M., Maheshwaran, S., Griffith, J., Li, J., Sheppard, M.C., Olliff, J. & Franklyn, J.A. (1993) Pituitary imaging is essential for women with moderate hyperprolactinaemia. British Medical Journal, 306, 507-508.
19. Thomas, D.J.B., Touzel, R., Charlesworth, M., Wass, J.A.H. & Besser, G.M. (1987) Hyperprolactinaemia and microadenomas in primary hypothyroidism. Clinical Endocrinology, 27, 289-295.
20. Toft, A.D., Boyns, A.R., Cole, E.N., Groom, G.V., Hunter, W.M. & Irvine, W.J. (1973) The effects of thyrotrophin-releasing hormone on plasma prolactin and thyrotrophin levels in primary hypothyroidism. Clinical Endocrinology, 2, 289-295.
21. Tunbridge, W.M.G., Evered, D.C., Hall, R., Appleton, D., Brewis, M., Clark, F., Grimley Evans, J., Young, E., Bird, T. & Smith, P.A. (1977) The spectrum of thyroid disease in the community: the Whickham Survey. Clinical Endocrinology, 7, 481-493.
22. Vanderpump, M.P.J., Tunbridge, W.M.G., French, J.M., Appleton, D., Bates, D., Clark, F., Grimley Evans, J., Hasan, D.M., Rodgers, H., Tunbridge, F. & Young, E.T. (1995) The incidence of thyroid disorders in the community - a twenty-year follow-up of the Whickham Survey. Clinical Endocrinology, 43, 55-69.
23. Vanderpump, M.P.J., Tunbridge, W.M.G., French, J.M., Appleton, D., Bates, D., Clark, F., Grimley Evans, J., Rodgers, H., Tunbridge, F. & Young, E.T. (1996) The development of ischemic heart disease in relation to autoimmune thyroid disease in a 20-year follow-up study of an English community. Thyroid, 6, 155-160.
24. Wilson, C.B. (1984) A decade of pituitary microsurgery. Journal of Neurosurgery, 61, 814-833.